Advertisement

Adnexal and Sebaceous Carcinomas

Published:October 27, 2022DOI:https://doi.org/10.1016/j.det.2022.07.010

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mehregan A.H.
        The origin of the adnexal tumors of the skin: a viewpoint.
        J Cutan Pathol. 1985; 12: 459-467
        • Blake P.W.
        • Bradford P.T.
        • Devesa S.S.
        • et al.
        Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study.
        Arch Dermatol. 2010; 146: 625-632https://doi.org/10.1001/archdermatol.2010.105
        • Avraham J.B.
        • Villines D.
        • Maker V.K.
        • et al.
        Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
        J Surg Oncol. 2013; 108: 57-62https://doi.org/10.1002/jso.23346
        • Tolkachjov S.N.
        Adnexal Carcinomas Treated With Mohs Micrographic Surgery: A Comprehensive Review.
        Dermatol Surg. 2017; 43: 1199-1207https://doi.org/10.1097/DSS.0000000000001167
        • Belousova I.E.
        • Kazakov D.V.
        • Michal M.
        • et al.
        Vulvar toker cells: the long-awaited missing link: a proposal for an origin-based histogenetic classification of extramammary paget disease.
        Am J Dermatopathol. 2006; 28: 84-86https://doi.org/10.1097/01.dad.0000194052.65695.f1
        • Merritt B.G.
        • Degesys C.A.
        • Brodland D.G.
        Extramammary Paget Disease.
        Dermatol Clin. 2019; 37: 261-267https://doi.org/10.1016/j.det.2019.02.002
        • Morris C.R.
        • Hurst E.A.
        Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up.
        Dermatol Surg. 2020; 46: 151-158https://doi.org/10.1097/dss.0000000000002064
        • Fanning J.
        • Lambert H.C.
        • Hale T.M.
        • et al.
        Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision.
        Am J Obstet Gynecol. 1999; 180: 24-27https://doi.org/10.1016/s0002-9378(99)70143-2
        • Kageyama N.
        • Izumi A.K.
        Bilateral scrotal extramammary Paget's disease in a Chinese man.
        Int J Dermatol. 1997; 36: 695-697https://doi.org/10.1046/j.1365-4362.1997.00044.x
        • Lee K.Y.
        • Roh M.R.
        • Chung W.G.
        • Chung K.Y.
        Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's Disease: Korean experience.
        Dermatol Surg. 2009; 35: 34-40https://doi.org/10.1111/j.1524-4725.2008.34380.x
        • Morris C.R.
        • Hurst E.A.
        Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.
        Dermatol Surg. 2020; 46: 305-311https://doi.org/10.1097/dss.0000000000002240
        • Schmitt A.R.
        • Long B.J.
        • Weaver A.L.
        • et al.
        Evidence-Based Screening Recommendations for Occult Cancers in the Setting of Newly Diagnosed Extramammary Paget Disease.
        Mayo Clin Proc. 2018; 93: 877-883https://doi.org/10.1016/j.mayocp.2018.02.024
        • Karam A.
        • Dorigo O.
        Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease.
        Gynecol Oncol. 2012; 125: 346-351https://doi.org/10.1016/j.ygyno.2012.01.032
        • Goldstein D.J.
        • Barr R.J.
        • Santa Cruz D.J.
        Microcystic adnexal carcinoma: a distinct clinicopathologic entity.
        Cancer. 1982; 50: 566-572
        • Amon G.
        • Liszewski W.
        • Maher I.A.
        Epidemiology and Survival of Microcystic Adnexal Carcinoma by Sex in the United States.
        Dermatol Surg. 2021; 47: 127-129https://doi.org/10.1097/DSS.0000000000002167
        • Billingsley E.M.
        • Fedok F.
        • Maloney M.E.
        Microcystic adnexal carcinoma. Case report and review of the literature.
        Arch Otolaryngol Head Neck Surg. 1996; 122: 179-182https://doi.org/10.1001/archotol.1996.01890140065012
        • Gordon S.
        • Fischer C.
        • Martin A.
        • Rosman I.S.
        • Council M.L.
        Microcystic Adnexal Carcinoma: A Review of the Literature.
        Dermatol Surg. 2017; 43: 1012-1016https://doi.org/10.1097/DSS.0000000000001142
        • Bier-Laning C.M.
        • Hom D.B.
        • Gapany M.
        • Manivel J.C.
        • Duvall 3rd, A.J.
        Microcystic adnexal carcinoma: management options based on long-term follow-up.
        Laryngoscope. 1995; 105: 1197-1201https://doi.org/10.1288/00005537-199511000-00011
        • Behbahani S.
        • Yeh C.J.
        • Pinto J.O.
        • et al.
        Microcystic adnexal carcinoma of the head and neck: Characteristics, treatment, and survival statistics.
        Dermatol Ther. 2021; 34: e14559https://doi.org/10.1111/dth.14559
        • Gauerke S.
        • Driscoll J.J.
        Hidradenocarcinomas: a brief review and future directions.
        Arch Pathol Lab Med. 2010; 134: 781-785
        • Cooper P.H.
        Carcinomas of sweat glands.
        Pathol Annu. 1987; 22: 83-124
        • Tolkachjov S.N.
        • Hocker T.L.
        • Hochwalt P.C.
        • et al.
        Mohs micrographic surgery for the treatment of hidradenocarcinoma: the Mayo Clinic experience from 1993 to 2013.
        Dermatol Surg. 2015; 41: 226-231https://doi.org/10.1097/DSS.0000000000000242
        • Soni A.
        • Bansal N.
        • Kaushal V.
        • et al.
        Current management approach to hidradenocarcinoma: a comprehensive review of the literature.
        Ecancermedicalscience. 2015; 9: 517https://doi.org/10.3332/ecancer.2015.517
        • Lim S.C.
        • Lee M.J.
        • Lee M.S.
        • et al.
        Giant hidradenocarcinoma: a report of malignant transformation from nodular hidradenoma.
        Pathol Int. 1998; 48: 818-823https://doi.org/10.1111/j.1440-1827.1998.tb03843.x
        • Cohen M.
        • Cassarino D.S.
        • Shih H.B.
        • et al.
        Apocrine hidradenocarcinoma of the scalp: a classification conundrum.
        Head Neck Pathol. 2009; 3: 42-46https://doi.org/10.1007/s12105-008-0096-8
        • Brown Jr., C.W.
        • Dy L.C.
        Eccrine porocarcinoma.
        Dermatol Ther. 2008; 21: 433-438https://doi.org/10.1111/j.1529-8019.2008.00243.x
        • Tolkachjov S.N.
        • Hocker T.L.
        • Camilleri M.J.
        • et al.
        Treatment of Porocarcinoma With Mohs Micrographic Surgery: The Mayo Clinic Experience.
        Dermatol Surg. 2016; 42: 745-750https://doi.org/10.1097/DSS.0000000000000763
        • Snow S.N.
        • Reizner G.T.
        Eccrine porocarcinoma of the face.
        J Am Acad Dermatol. 1992; 27: 306-311https://doi.org/10.1016/0190-9622(92)70187-k
        • Song S.S.
        • Wu Lee W.
        • Hamman M.S.
        • et al.
        Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature.
        Dermatol Surg. 2015; 41: 301-306https://doi.org/10.1097/DSS.0000000000000286
        • Robson A.
        • Greene J.
        • Ansari N.
        • et al.
        Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases.
        Am J Surg Pathol. 2001; 25: 710-720https://doi.org/10.1097/00000478-200106000-00002
        • Behbahani S.
        • Malerba S.
        • Karanfilian K.M.
        • et al.
        Demographics and outcomes of eccrine porocarcinoma: results from the National Cancer Database.
        Br J Dermatol. 2020; 183: 161-163https://doi.org/10.1111/bjd.18874
        • Lennox B.
        • Pearse A.G.
        • Richards H.G.
        Mucin-secreting tumours of the skin with special reference to the so-called mixed-salivary tumour of the skin and its relation to hidradenoma.
        J Pathol Bacteriol. 1952; 64: 865-880https://doi.org/10.1002/path.1700640418
        • Breiting L.
        • Christensen L.
        • Dahlstrøm K.
        • et al.
        Primary mucinous carcinoma of the skin: a population-based study.
        Int J Dermatol. 2008; 47: 242-245https://doi.org/10.1111/j.1365-4632.2008.03558.x
        • Kamalpour L.
        • Brindise R.T.
        • Nodzenski M.
        • et al.
        Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery.
        JAMA Dermatol. 2014; 150: 380-384https://doi.org/10.1001/jamadermatol.2013.6006
        • Reid-Nicholson M.
        • Iyengar P.
        • Friedlander M.A.
        • et al.
        Fine needle aspiration biopsy of primary mucinous carcinoma of the skin: a case report.
        Acta Cytol. 2006; 50: 317-322https://doi.org/10.1159/000325961
        • Behbahani S.
        • Pinto J.O.
        • Wassef D.
        • et al.
        Analysis of Head and Neck Primary Cutaneous Mucinous Carcinoma: An Indolent Tumor of the Eccrine Sweat Glands.
        J Craniofac Surg. 2021; 32: e244-e247https://doi.org/10.1097/scs.0000000000006968
        • Agni M.
        • Raven M.L.
        • Bowen R.C.
        • et al.
        An Update on Endocrine Mucin-producing Sweat Gland Carcinoma: Clinicopathologic Study of 63 Cases and Comparative Analysis.
        Am J Surg Pathol. 2020; 44: 1005-1016https://doi.org/10.1097/pas.0000000000001462
        • Borik L.
        • Heller P.
        • Shrivastava M.
        • et al.
        Malignant cylindroma in a patient with Brooke-Spiegler syndrome.
        Dermatol Pract Concept. 2015; 5: 61-65https://doi.org/10.5826/dpc.0502a09
        • Dabska M.
        Malignant transformation of eccrine spiradenoma.
        Pol Med J. 1972; 11: 388-396
        • Balci M.G.
        • Tayfur M.
        • Deger A.N.
        • et al.
        Aggressive papillary adenocarcinoma on atypical localization: A unique case report.
        Medicine (Baltimore). 2016; 95: e4110https://doi.org/10.1097/md.0000000000004110
        • Hsu H.C.
        • Ho C.Y.
        • Chen C.H.
        • et al.
        Aggressive digital papillary adenocarcinoma: a review.
        Clin Exp Dermatol. 2010; 35: 113-119https://doi.org/10.1111/j.1365-2230.2009.03490.x
        • Ferreira S.
        • Conde Fernandes I.
        • Coelho A.
        • et al.
        Primary cutaneous adenoid cystic carcinoma of the abdomen: a rare entity.
        Dermatol Online J. 2020; 26 (13030/qt0q979406)
        • Rocas D.
        • Asvesti C.
        • Tsega A.
        • et al.
        Primary adenoid cystic carcinoma of the skin metastatic to the lymph nodes: immunohistochemical study of a new case and literature review.
        Am J Dermatopathol. 2014; 36: 223-228https://doi.org/10.1097/DAD.0b013e31829ae1e7
        • van der Kwast T.H.
        • Vuzevski V.D.
        • Ramaekers F.
        • et al.
        Primary cutaneous adenoid cystic carcinoma: case report, immunohistochemistry, and review of the literature.
        Br J Dermatol. 1988; 118: 567-577https://doi.org/10.1111/j.1365-2133.1988.tb02469.x
        • Sánchez Herreros C.
        • Belmar Flores P.
        • De Eusebio Murillo E.
        • et al.
        A case of cutaneous malignant mixed tumor treated with mohs micrographic surgery.
        Dermatol Surg. 2011; 37: 267-270https://doi.org/10.1111/j.1524-4725.2010.01865.x
        • Lal K.
        • Morrell T.J.
        • Cunningham M.
        • et al.
        A Case of a Malignant Cutaneous Mixed Tumor (Chondroid Syringoma) of the Scapula Treated With Staged Margin-Controlled Excision.
        Am J Dermatopathol. 2018; 40: 679-681https://doi.org/10.1097/dad.0000000000001131
        • Llamas-Velasco M.
        • Mentzel T.
        • Rütten A.
        Primary cutaneous secretory carcinoma: A previously overlooked low-grade sweat gland carcinoma.
        J Cutan Pathol Mar. 2018; 45: 240-245https://doi.org/10.1111/cup.13092
        • Ahn C.S.
        • Sangüeza O.P.
        Malignant Sweat Gland Tumors.
        Hematol Oncol Clin North Am. 2019; 33: 53-71https://doi.org/10.1016/j.hoc.2018.09.002
        • Miyamoto T.
        • Hagari Y.
        • Inoue S.
        • et al.
        Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature.
        J Clin Pathol. 2005; 58: 757-761https://doi.org/10.1136/jcp.2004.019794
        • Dhawan S.S.
        • Nanda V.S.
        • Grekin S.
        • et al.
        Apocrine adenocarcinoma: case report and review of the literature.
        J Dermatol Surg Oncol. 1990; 16: 468-470https://doi.org/10.1111/j.1524-4725.1990.tb00066.x
        • Chamberlain R.S.
        • Huber K.
        • White J.C.
        • et al.
        Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment.
        Am J Clin Oncol. 1999; 22: 131-135https://doi.org/10.1097/00000421-199904000-00005
        • Rütten A.
        • Kutzner H.
        • Mentzel T.
        • et al.
        Primary cutaneous cribriform apocrine carcinoma: a clinicopathologic and immunohistochemical study of 26 cases of an under-recognized cutaneous adnexal neoplasm.
        J Am Acad Dermatol. 2009; 61: 644-651https://doi.org/10.1016/j.jaad.2009.03.032
        • Arps D.P.
        • Chan M.P.
        • Patel R.M.
        • et al.
        Primary cutaneous cribriform carcinoma: report of six cases with clinicopathologic data and immunohistochemical profile.
        J Cutan Pathol. 2015; 42: 379-387https://doi.org/10.1111/cup.12469
        • Durani B.K.
        • Kurzen H.
        • Jaeckel A.
        • et al.
        Malignant transformation of multiple dermal cylindromas.
        Br J Dermatol. 2001; 145: 653-656https://doi.org/10.1046/j.1365-2133.2001.04460.x
        • Russ B.W.
        • Meffert J.
        • Bernert R.
        Spiradenocarcinoma of the scalp.
        Cutis. 2002; 69: 455-458
        • Chen E.L.A.
        • Nijhawan R.I.
        Aggressive Digital Papillary Adenocarcinoma Initially Misdiagnosed as Basal Cell Carcinoma.
        Dermatol Surg. 2021; 47: 137-139https://doi.org/10.1097/dss.0000000000002173
        • Knackstedt R.W.
        • Knackstedt T.J.
        • Findley A.B.
        • et al.
        Aggressive digital papillary adenocarcinoma: treatment with Mohs micrographic surgery and an update of the literature.
        Int J Dermatol. 2017; 56: 1061-1064https://doi.org/10.1111/ijd.13712
        • Naylor E.
        • Sarkar P.
        • Perlis C.S.
        • et al.
        Primary cutaneous adenoid cystic carcinoma.
        J Am Acad Dermatol. 2008; 58: 636-641https://doi.org/10.1016/j.jaad.2007.12.005
        • Kazakov D.V.
        • Kacerovska D.
        • Hantschke M.
        • et al.
        Cutaneous mixed tumor, eccrine variant: a clinicopathologic and immunohistochemical study of 50 cases, with emphasis on unusual histopathologic features.
        Am J Dermatopathol. 2011; 33: 557-568https://doi.org/10.1097/DAD.0b013e318206c1a3
        • Tolkachjov S.N.
        • Brewer J.D.
        • Bridges A.G.
        Apocrine Axillary Adenocarcinoma: An Aggressive Adnexal Tumor in Middle-Age Individuals.
        Dermatol Surg. 2018; 44: 876-878https://doi.org/10.1097/dss.0000000000001430
        • Wu J.D.
        • Changchien C.H.
        • Liao K.S.
        Primary cutaneous cribriform apocrine carcinoma: Case report and literature review.
        Indian J Dermatol Venereol Leprol. 2018; 84: 569-572https://doi.org/10.4103/ijdvl.IJDVL_830_16
        • Asel M.
        • LeBoeuf N.R.
        Extramammary Paget's Disease.
        Hematol Oncol Clin North Am. 2019; 33: 73-85https://doi.org/10.1016/j.hoc.2018.09.003
        • Hatta N.
        • Morita R.
        • Yamada M.
        • et al.
        Sentinel lymph node biopsy in patients with extramammary Paget's disease.
        Dermatol Surgt. 2004; 30: 1329-1334https://doi.org/10.1111/j.1524-4725.2004.30377.x
        • Worley B.
        • Owen J.L.
        • Barker C.A.
        • et al.
        Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma: Informed by a Systematic Review.
        JAMA Dermatol. 2019; 155: 1059-1068https://doi.org/10.1001/jamadermatol.2019.1251
        • Belin E.
        • Ezzedine K.
        • Stanislas S.
        • et al.
        Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure.
        Br J Dermatol. 2011; 165: 985-989https://doi.org/10.1111/j.1365-2133.2011.10486.x
        • Shaw M.
        • McKee P.H.
        • Lowe D.
        • et al.
        Malignant eccrine poroma: a study of twenty-seven cases.
        Br J Dermatol. 1982; 107: 675-680https://doi.org/10.1111/j.1365-2133.1982.tb00527.x
        • Wick M.R.
        • Goellner J.R.
        • Wolfe 3rd, J.T.
        • et al.
        Adnexal carcinomas of the skin. I. Eccrine carcinomas.
        Cancer. 1985; 56: 1147-1162
        • Adefusika J.A.
        • Pimentel J.D.
        • Chavan R.N.
        • et al.
        Primary mucinous carcinoma of the skin: the Mayo Clinic experience over the past 2 decades.
        Dermatol Surg. 2015; 41: 201-208https://doi.org/10.1097/dss.0000000000000198
        • Kuklani R.M.
        • Glavin F.L.
        • Bhattacharyya I.
        Malignant cylindroma of the scalp arising in a setting of multiple cylindromatosis: a case report.
        Head Neck Pathol. 2009; 3: 315-319https://doi.org/10.1007/s12105-009-0138-x
        • Lo J.S.
        • Peschen M.
        • Snow S.N.
        • et al.
        Malignant cylindroma of the scalp.
        J Dermatol Surg Oncol. 1991; 17: 897-901https://doi.org/10.1111/j.1524-4725.1991.tb03281.x
        • Staiger R.D.
        • Helmchen B.
        • Papet C.
        • et al.
        Spiradenocarcinoma: A Comprehensive Data Review.
        Am J Dermatopathol. 2017; 39: 715-725https://doi.org/10.1097/dad.0000000000000910
        • Altman C.E.
        • Hamill R.L.
        • Elston D.M.
        Metastatic aggressive digital papillary adenocarcinoma.
        Cutis. 2003; 72: 145-147
        • Kempton S.J.
        • Navarrete A.D.
        • Salyapongse A.N.
        Aggressive Digital Papillary Adenocarcinoma: Case Report of a Positive Sentinel Lymph Node and Discussion of Utility of Sentinel Lymph Node Biopsy.
        Ann Plast Surg. 2015; 75: 34-36https://doi.org/10.1097/sap.0000000000000111
        • Reis J.P.
        • Tellechea O.
        • Cunha M.F.
        • et al.
        Trichilemmal carcinoma: review of 8 cases.
        J Cutan Pathol. 1993; 20: 44-49https://doi.org/10.1111/j.1600-0560.1993.tb01248.x
        • Hamman M.S.
        • Brian Jiang S.I.
        Management of trichilemmal carcinoma: an update and comprehensive review of the literature.
        Dermatol Sur. 2014; 40: 711-717https://doi.org/10.1111/dsu.0000000000000002
        • Wong T.Y.
        • Suster S.
        Tricholemmal carcinoma. A clinicopathologic study of 13 cases.
        Am J Dermatopatho. 1994; 16: 463-473https://doi.org/10.1097/00000372-199410000-00001
        • Boscaino A.
        • Terracciano L.M.
        • Donofrio V.
        • et al.
        Tricholemmal carcinoma: a study of seven cases.
        J Cutan Pathol. 1992; 19: 94-99https://doi.org/10.1111/j.1600-0560.1992.tb01349.x
        • Lever W.F.
        • Griesemer R.D.
        Calcifying epithelioma of Malherbe; report of 15 cases, with comments on its differentiation from calcified epidermal cyst and on its histogenesis.
        Arch Derm Syphilol. 1949; 59: 506-518https://doi.org/10.1001/archderm.1949.01520300016003
        • Allaoui M.
        • Hubert E.
        • Michels J.J.
        Malignant pilomatricoma: two new observations and review of the relevant literature.
        Turk Patoloji Derg. 2014; 30: 66-68https://doi.org/10.5146/tjpath.2013.01205
        • Jones C.
        • Twoon M.
        • Ho W.
        • et al.
        Pilomatrix carcinoma: 12-year experience and review of the literature.
        J Cutan Pathol. 2018; 45: 33-38https://doi.org/10.1111/cup.13046
        • Gazic B.
        • Sramek-Zatler S.
        • Repse-Fokter A.
        • et al.
        Pilomatrix carcinoma of the clitoris.
        Int J Surg Pathol. 2011; 19: 827-830https://doi.org/10.1177/1066896910397882
        • Sable D.
        • Snow S.N.
        Pilomatrix carcinoma of the back treated by mohs micrographic surgery.
        Dermatol Surg. 2004; 30: 1174-1176https://doi.org/10.1111/j.1524-4725.2004.30350.x
        • Xing L.
        • Marzolf S.A.
        • Vandergriff T.
        • et al.
        Facial pilomatrix carcinomas treated with Mohs micrographic surgery.
        JAAD Case Rep. 2018; 4: 253-255https://doi.org/10.1016/j.jdcr.2018.02.003
        • Boettler M.A.
        • Shahwan K.T.
        • Abidi N.Y.
        • et al.
        Trichoblastic carcinoma: a comprehensive review of the literature.
        Arch Dermatol Res. 2022; 314: 399-403
        • Schulz T.
        • Proske S.
        • Hartschuh W.
        • et al.
        High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread.
        Am J Dermatopathol. 2005; 27: 9-16https://doi.org/10.1097/01.dad.0000142240.93956.cb
        • Kwock J.T.
        • Casady M.
        • Handfield C.
        • et al.
        A trichogenic tumor with aggressive features initially diagnosed as basal cell carcinoma.
        Dermatol Online J. 2018; 24
        • Toberer F.
        • Rütten A.
        • Requena L.
        • et al.
        Eosinophil-rich trichoblastic carcinoma with aggressive clinical course in a young man.
        J Cutan Pathol. 2017; 44: 986-990https://doi.org/10.1111/cup.13031
        • Battistella M.
        • Mateus C.
        • Lassau N.
        • et al.
        Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma.
        J Eur Acad Dermatol Venereol. 2010; 24: 199-203https://doi.org/10.1111/j.1468-3083.2009.03301.x
        • Regauer S.
        • Beham-Schmid C.
        • Okcu M.
        • et al.
        Trichoblastic carcinoma ("malignant trichoblastoma") with lymphatic and hematogenous metastases.
        Mod Pathol. 2000; 13: 673-678https://doi.org/10.1038/modpathol.3880118
        • Nguyen B.D.
        • Seetharam M.
        • Ocal T.I.
        18F-FDG PET/CT Imaging of Trichoblastic Carcinoma With Nodal Metastasis.
        Clin Nucl Med. 2019; 44: e423-e424https://doi.org/10.1097/rlu.0000000000002622
        • Laffay L.
        • Depaepe L.
        • d'Hombres A.
        • et al.
        Histological features and treatment approach of trichoblastic carcinomas: from a case report to a review of the literature.
        Tumori. 2012; 98: 46e-49ehttps://doi.org/10.1700/1088.11948
        • Owen J.L.
        • Kibbi N.
        • Worley B.
        • et al.
        Sebaceous carcinoma: evidence-based clinical practice guidelines.
        Lancet Oncol. 2019; 20: e699-e714https://doi.org/10.1016/s1470-2045(19)30673-4
        • Hoss E.
        • Nelson S.A.
        • Sharma A.
        Sebaceous carcinoma in solid organ transplant recipients.
        Int J Dermatol. 2017; 56: 746-749https://doi.org/10.1111/ijd.13490
        • Nelson B.R.
        • Hamlet K.R.
        • Gillard M.
        • et al.
        Sebaceous carcinoma.
        J Am Acad Dermatol. 1995; 33 (quiz 16-8): 1-15https://doi.org/10.1016/0190-9622(95)90001-2
        • Esmaeli B.
        • Nasser Q.J.
        • Cruz H.
        • et al.
        American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
        Ophthalmology. 2012; 119: 1078-1082https://doi.org/10.1016/j.ophtha.2011.11.006
        • Kyllo R.L.
        • Brady K.L.
        • Hurst E.A.
        Sebaceous carcinoma: review of the literature.
        Dermatol Surg. 2015; 41: 1-15https://doi.org/10.1097/dss.0000000000000152
        • Tryggvason G.
        • Bayon R.
        • Pagedar N.A.
        Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management.
        Head Neck. 2012; 34: 1765-1768https://doi.org/10.1002/hed.22009
        • Garcia A.
        • Nguyen J.M.
        • Stetson C.L.
        • et al.
        Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?.
        JAAD Case Rep. 2020; 6: 561-562https://doi.org/10.1016/j.jdcr.2020.02.004
        • Leeman A.
        • de Cuba E.M.V.
        • Jaspars L.H.
        • et al.
        A Low-Grade Trichoblastic Carcinoma Treated with Mohs Micrographic Surgery.
        Case Rep Dermatol. 2021; 13: 129-133https://doi.org/10.1159/000512871
        • Tolkachjov S.N.
        • Hocker T.L.
        • Camilleri M.J.
        • et al.
        Mohs micrographic surgery in the treatment of trichilemmal carcinoma: the Mayo Clinic experience.
        J Am Acad Dermatol. 2015; 72: 195-196https://doi.org/10.1016/j.jaad.2014.10.007
        • Ha J.H.
        • Lee C.
        • Lee K.S.
        • et al.
        The molecular pathogenesis of Trichilemmal carcinoma.
        BMC Cancer. 2020; 20: 516https://doi.org/10.1186/s12885-020-07009-7
        • Nishioka M.
        • Tanemura A.
        • Yamanaka T.
        • et al.
        Pilomatrix carcinoma arising from pilomatricoma after 10-year senescent period: Immunohistochemical analysis.
        J Dermatol. 2010; 37: 735-739https://doi.org/10.1111/j.1346-8138.2010.00887.x
        • Herrmann J.L.
        • Allan A.
        • Trapp K.M.
        • et al.
        Pilomatrix carcinoma: 13 new cases and review of the literature with emphasis on predictors of metastasis.
        J Am Acad Dermatol. 2014; 71: 38-43.e2